Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Universidade Federal de Pernambuco | OTHER |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is verify the effects of a 8 weeks strength training, on balance, neuromuscular performance and symptomatology of fibromyalgia.
Thirty participants will be recruited. Volunteers will be randomly assigned to the control group or experimental group. Before the training period, symptoms, balance and neuromuscular performance will be assessed. Participants in the experimental group will perform strength training twice a week (50 min each) for eight weeks. Then, four weeks of detraining will be completed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise | Experimental | 8 weeks of strength training. |
|
| Control | No Intervention | Maintain their usual medical treatment and daily routines |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Strength exercise | Other | The protocol consists of 8 weeks of training, consisting of 16 sessions of 50 minutes, twice a week on alternate days. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Balance | Force plate | Change from Baseline balance at week 9 |
| Balance | Force plate | Change from Baseline balance at week 12 |
| Balance | Force plate | Change from week 9 balance at week 12 |
| Neuromuscular performance | Optical measurement system consisting of two transmitting and receiving cells to assess vertical jump and medicine ball to assess strength of the upper limbs. | Change from Baseline neuromuscular performance at week 9 |
| Neuromuscular performance | Optical measurement system consisting of two transmitting and receiving cells to assess vertical jump and medicine ball to assess strength of the upper limbs. | Change from Baseline neuromuscular performance at week 12 |
| Neuromuscular performance | Optical measurement system consisting of two transmitting and receiving cells to assess vertical jump and medicine ball to assess strength of the upper limbs. | Change from week 9 neuromuscular performance at week 12 |
| Measure | Description | Time Frame |
|---|---|---|
| Fibromyalgia impact questionnaire | Questionnaire to ccess information on the functional capacity and health status of individuals with fibromyalgia. Composed of 20 questions. , the values vary from 0 to 100, in which the higher the value, the greater the impact of fibromyalgia. | Baseline, week 9, week 12 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Investigator | University of Beira Interior | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Federal University of Pernambuco | Recife | Pernambuco | 50670-901 | Brazil |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37188309 | Derived | Albuquerque MLL, Monteiro D, Alvarez MC, Vilarino GT, Andrade A, Neiva HP. Effects of strength training in fibromyalgia on balance, neuromuscular performance, and symptomatic analysis: a 12-week study protocol. Front Neurol. 2023 Apr 28;14:1149268. doi: 10.3389/fneur.2023.1149268. eCollection 2023. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005356 | Fibromyalgia |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D009468 | Neuromuscular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Pain intensity |
Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose. |
| baseline and everyday until the week 12 |
| Anxiety | Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose. | baseline and everyday until the week 12 |
| Quality of sleep | Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose. | baseline and everyday until the week 12 |
| Fatigue | Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose. | baseline and everyday until the week 12 |
| Mood state | Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose. | baseline and everyday until the week 12 |
| D009422 |
| Nervous System Diseases |